Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
Record 1 of 5
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title Assessing and improving value in cancer care : workshop summary / Adam Schickedanz, rapporteur ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
Imprint Washington, D.C. : National Academies Press, [2009]

Subject Cancer -- Patients -- Medical care.
Cancer -- Treatment -- Economic aspects.
Neoplasms -- prevention & control.
Economics, Medical.
Neoplasms -- therapy.
Neoplasms -- economics.
Neoplasms -- therapy.
Neoplasms -- economics.
Cost-Benefit Analysis.
Neoplasms -- economics.
Neoplasms -- therapy.
Outcome Assessment, Health Care -- economics.
United States.
United States.
Alt Name Schickedanz, Adam.
National Cancer Policy Forum (U.S.)
Description 1 online resource (xvi, 148 pages) : illustrations
polychrome rdacc
Bibliography Note Includes bibliographical references.
Contents Introduction -- Opening remarks: what is value in cancer care and why is it important? -- Part I. Challenges to value in cancer care. Clinician-patient communication and its influence and value -- Generating evidence about effectiveness and value -- Value and the oncology market -- Value in oncology practice; oncologist and health insurer perspectives -- pt. II. Ethical issues and value in oncology. Solutions for value in cancer care -- Improving value in oncology practice: ways forward -- Toward a shared understanding of value -- Acronyms -- Glossary -- Appendix A. Workshop agenda -- Appendix B. Speaker and moderator biographies.
Summary "Unlike many other areas in health care, the practice of oncology presents unique challenges that make assessing and improving value especially complex. First, patients and professionals feel a well-justified sense of urgency to treat for cure, and if cure is not possible, to extend life and reduce the burden of disease. Second, treatments are often both life sparing and highly toxic. Third, distinctive payment structures for cancer medicines are intertwined with practice. Fourth, providers often face tremendous pressure to apply the newest technologies to patients who fail to respond to established treatments, even when the evidence supporting those technologies is incomplete or uncertain, and providers may be reluctant to stop toxic treatments and move to palliation, even at the end of life. Finally, the newest and most novel treatments in oncology are among the most costly in medicine. This volume summarizes the results of a workshop that addressed these issues from multiple perspectives, including those of patients and patient advocates, providers, insurers, health care researchers, federal agencies, and industry. Its broad goal was to describe value in oncology in a complete and nuanced way, to better inform decisions regarding developing, evaluating, prescribing, and paying for cancer therapeutics."--Publisher's description.
Note Print version record.
ISBN 9780309138154 (electronic bk.)
0309138159 (electronic bk.)
OCLC # 649901506
Additional Format Print version: Assessing and improving value in cancer care. Washington, D.C. : National Academies Press, ©2009 9780309138147 (OCoLC)472200978

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team